UBS Group
HCM icon

UBS Group’s HUTCHMED HCM Stock Holding History

UBS Group’s Portfolio HCM Stock Details HCM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$670K Sell
44,758
-16,002
-26% -$234K ﹤0.01% 5851
2025
Q4 		$810K Sell
60,760
-76,240
-56% -$1.11M ﹤0.01% 5749
2025
Q3 		$2.16M Buy
137,000
+72,614
+113% +$1.19M ﹤0.01% 4876
2025
Q2 		$969K Sell
64,386
-152,179
-70% -$2.22M ﹤0.01% 5473
2025
Q1 		$3.26M Sell
216,565
-161,163
-43% -$2.38M ﹤0.01% 4234
2024
Q4 		$5.44M Buy
377,728
+274,090
+264% +$4.9M ﹤0.01% 3752
2024
Q3 		$2.02M Buy
103,638
+68,636
+196% +$1.24M ﹤0.01% 3980
2024
Q2 		$599K Buy
35,002
+18,007
+106% +$332K ﹤0.01% 4863
2024
Q1 		$286K Sell
16,995
-18,811
-53% -$285K ﹤0.01% 5603
2023
Q4 		$648K Sell
35,806
-9,392
-21% -$171K ﹤0.01% 4875
2023
Q3 		$766K Sell
45,198
-1,638
-3% -$23.5K ﹤0.01% 4321
2023
Q2 		$562K Sell
46,836
-11,012
-19% -$150K ﹤0.01% 4722
2023
Q1 		$753K Buy
57,848
+1,401
+2% +$23K ﹤0.01% 4354
2022
Q4 		$834K Sell
56,447
-93,847
-62% -$1.03M ﹤0.01% 4243
2022
Q3 		$1.33M Buy
150,294
+10,485
+7% +$132K ﹤0.01% 3496
2022
Q2 		$1.77M Sell
139,809
-13,183
-9% -$168K ﹤0.01% 3258
2022
Q1 		$2.9M Sell
152,992
-1,953
-1% -$49.7K ﹤0.01% 3084
2021
Q4 		$5.43M Buy
154,945
+6,420
+4% +$209K ﹤0.01% 2739
2021
Q3 		$5.44M Buy
148,525
+6,066
+4% +$239K ﹤0.01% 2580
2021
Q2 		$5.59M Buy
142,459
+22,463
+19% +$649K ﹤0.01% 2562
2021
Q1 		$3.39M Sell
119,996
-13,228
-10% -$422K ﹤0.01% 3008
2020
Q4 		$4.27M Sell
133,224
-960
-0.7% -$29.5K ﹤0.01% 2617
2020
Q3 		$4.33M Buy
134,184
+2,144
+2% +$66.8K ﹤0.01% 2338
2020
Q2 		$3.64M Buy
132,040
+21,557
+20% +$468K ﹤0.01% 2316
2020
Q1 		$1.97M Sell
110,483
-9,406
-8% -$227K ﹤0.01% 2777
2019
Q4 		$3.01M Sell
119,889
-8,481
-7% -$186K ﹤0.01% 3130
2019
Q3 		$2.29M Buy
128,370
+18,069
+16% +$376K ﹤0.01% 3161
2019
Q2 		$2.43M Sell
110,301
-6,787
-6% -$194K ﹤0.01% 2968
2019
Q1 		$3.58M Buy
117,088
+17,999
+18% +$449K ﹤0.01% 2482
2018
Q4 		$2.29M Sell
99,089
-10,879
-10% -$338K ﹤0.01% 2903
2018
Q3 		$3.54M Buy
109,968
+109,537
+25,415% +$3.34M ﹤0.01% 2676
2018
Q2 		$13K Sell
431
-2,181
-83% -$69.3K ﹤0.01% 6984
2018
Q1 		$78K Buy
2,612
+587
+29% +$20.9K ﹤0.01% 5397
2017
Q4 		$80K Buy
2,025
+1,802
+808% +$57.6K ﹤0.01% 5514
2017
Q3 		$6K Buy
+223
New +$5.47K ﹤0.01% 7147
2016
Q4 		– Sell
-57
Closed -$1K – 7874
2016
Q3 		$1K Buy
+57
New +$728 ﹤0.01% 7516
2016
Q2 		– Sell
-2,474
Closed -$33K – 7822
2016
Q1 		$33K Buy
+2,474
New +$33.1K ﹤0.01% 5813

Other funds holding HCM

Schroder Investment Management Group
Schroder Investment Management Group London, United Kingdom $122B AUM 29.27% 1-Year Est. Return
Allianz Asset Management
Allianz Asset Management Munich, Germany $95.4B AUM 38.74% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AG
AIA Group Hong Kong $6.88B AUM 20.97% 1-Year Est. Return
MGP
M&G plc London, United Kingdom $19.4B AUM 16.7% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
BNP Paribas Financial Markets
BNP Paribas Financial Markets Paris, France $206B AUM 31.61% 1-Year Est. Return
CGH
Crossmark Global Holdings Houston, Texas $7.71B AUM 37.66% 1-Year Est. Return
Jane Street
Jane Street New York $777B AUM 61.18% 1-Year Est. Return

UBS Group's HCM Position: Q1 2026 in Review

UBS Group reduced its HUTCHMED (HCM) stake by 26% in Q1 2026, selling an estimated $234K and leaving 44,758 shares worth $670K. The position accounts for ﹤0.01% of the portfolio, ranked #5851.

UBS Group first reported a position in HCM in Q1 2016 and has held it in 37 quarters since. The position peaked at $5.59M in Q2 2021. 54 funds tracked by Wall St. Rank hold HCM as of Q1 2026.

  • UBS Group held 44,758 shares of HUTCHMED worth $670K as of Q1 2026.
  • UBS Group sold 16,002 HUTCHMED shares in Q1 2026, an estimated $234K.
  • HUTCHMED made up ﹤0.01% of UBS Group's portfolio in Q1 2026, its #5851 holding.
  • UBS Group first reported a position in HUTCHMED in Q1 2016 and has held it in 37 quarters since.
  • UBS Group's HUTCHMED position peaked at $5.59M in Q2 2021.
  • 54 funds tracked by Wall St. Rank held HUTCHMED as of Q1 2026.

Based on UBS Group's 13F filing for Q1 2026, filed 5 May 2026.